KINNATE BIOPHARMA INC earnings per share and revenue

6KB earnings per share for the last quarter are -0.35 EUR whereas the estimation was -0.35 EUR which accounts for 0.00% surprise. Estimated earnings per share for the next quarter are -0.36 EUR, and revenue is expected to reach 0.00 EUR. Also watch annual changes over time to get a bigger picture of 6KB earnings per share and revenue dynamics.